Pfizer applies for FDA authorization for Omicron booster vaccine for children under 5

Pfizer and its German partner BioNTech announced that they have applied to the US Food and Drug Administration for an emergency use authorisation for their Omicron-adjuvanted COVID-19 booster vaccine for children aged 6 months to 4 years.

Share this post:

Related Posts
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore
WordPress Cookie Plugin by Real Cookie Banner